Rodney Sinclair

Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.

Michela Starace, Matilde Iorizzo, Andrea Sechi, Aurora Maria Alessandrini, Miriam Carpanese, Francesca Bruni, Giulio Vara, Zoe Apalla, Daniel Asz-Sigall, Stefania Barruscotti, Francisco Camacho, Isabella Doche, Bruna Duque Estrada, Rachita Dhurat, Maria Fernanda Gavazzoni, Ramon Grimalt, Matthew Harries, Dimitrios Ioannidis, Amy McMichael, Daniel Fernandes Melo, et al.

Journal article  |  2021  |  JAAD Int

Background: The cutaneous manifestations of COVID-19 may be useful disease markers and prognostic indicators. Recently, postinfect..

Dermatology COVID-19 Registries

Esther E Freeman, Grace C Chamberlin, Devon E McMahon, George J Hruza, Dmitri Wall, Nekma Meah, Rodney Sinclair, Esther A Balogh, Steven R Feldman, Michelle A Lowes, Angelo V Marzano, Haley B Naik, Leslie Castelo-Soccio, Irene Lara-Corrales, Kelly M Cordoro, Satveer K Mahil, Christopher EM Griffiths, Catherine H Smith, Alan D Irvine, Phyllis I Spuls, et al.

Journal article  |  2021  |  Dermatologic Clinics

During the COVID-19 pandemic, rapid, real-world evidence is essential for the development of knowledge and subsequent public healt..

25985 Efficacy of tildrakizumab 100 mg for PASI improvement in patients with moderate to severe plaque psoriasis: Pooled analysis using nonresponder imputation from reSURFACE 1 and 2 through week 52

Mark G Lebwohl, Richard GB Langley, Rodney Sinclair, April W Armstrong, Alan M Mendelsohn, Stephen J Rozzo, Jerry Bagel

Journal article  |  2021  |  Journal of the American Academy of Dermatology

25995 5-year efficacy of tildrakizumab 100 and 200 mg by PASI 50/75/90/100 and PGA in reSURFACE 1

Andrew Blauvelt, Rodney Sinclair, Akihiko Asahina, Atsuyuki Igarashi, Alan M Mendelsohn, Stephen J Rozzo, Kimberly Eads, Scott Guenthner, Lyn Guenther

Journal article  |  2021  |  Journal of the American Academy of Dermatology

Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial

L Bokhari, LN Jones, RD Sinclair

Journal article  |  2021  |  JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Minoxidil is an approved medication for severe hypertension androgenetic alopecia. Oral minoxidil (OM) is potent vasodilator used ..

Disorders of Hair

Nooshin Bagherni, Mediha Hasić-Mujanović, Bruce R Smoller, Cynthia Reyes-Baron, Beata Bergler-Czop, Bartosz Miziołek, Emina Kasumagic-Halilovic, Rodney Sinclair, Janina Eliza Poa, Balachandra S Ankad, Negin Bagherani, Roxana Sahebnasagh

Book Chapter  |  2021

Alopecias in humans: biology, pathomechanisms and emerging therapies

Anneliese Willems, Rodney Sinclair

Journal article  |  2021  |  VETERINARY DERMATOLOGY

BACKGROUND: The hair follicle is a complete mini-organ with a complex biology. Recent discoveries have shed light on the pathogene..

Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study.

Rebekka Jerjen, Joel Pinczewski, Rodney Sinclair, Bevin Bhoyrul

Journal article  |  2021  |  J Eur Acad Dermatol Venereol

BACKGROUND: Fibrosing alopecia in a pattern distribution (FAPD) is a primary cicatricial alopecia considered a subtype of lichen p..

Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)

EA Olsen, M Harries, A Tosti, W Bergfeld, U Blume-Peytavi, V Callender, V Chasapi, O Correia, G Cotsarelis, R Dhurat, N Dlova, I Doche, N Enechukwu, R Grimalt, S Itami, M Hordinsky, K Khobzei, W-S Lee, S Malakar, A Messenger, et al.

Journal article  |  2021  |  BRITISH JOURNAL OF DERMATOLOGY

BACKGROUND: Frontal fibrosing alopecia (FFA) has become one of the most common causes of cicatricial alopecia worldwide. However, ..

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Rodney Sinclair, Ana B Pavel, Linda Zhu, Lori Ann Cox, Brittany Craiglow, Linda Chen, Christopher Banfield, Karen Page, Weidong Zhang, Michael S Vincent

Journal article  |  2021  |  JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

BACKGROUND: Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments. OBJECTIVE: To evaluate the efficacy a..